Daniel Dietz

Daniel Dietz 

Director 
With a primary expertise in go-to-market strategy and startup operations, Daniel specializes in new ventures in regulated markets. Using data-driven decision making, Daniel takes ideas through the proof-of-conceptstage, setting up ventures to scale.
Daniel has successfully helped to launch ventures in real estate, retail, cannabis, dietary supplements, and new technologies, navigating complex regulatory frameworks to mitigate risk and maximize growth potential.
Daniel has successfully launched the US-subsidiary of Longevity Labs, translating a single-SKU new EU-based longevity supplement for the US market and scaling to over $3.4M in annual run rate revenueand over 28,000 units sold within the first year of operations exclusively over eCommerce channels with less than $1.25M in seed funding.